Clinical investigations have provided evidence indicating that abnormalities or genetic variations in TGF-β-mediated signaling are associated with various reproductive issues, including polycystic ovary syndrome, ovulation failure, and ovarian malignancies [30]. Here, TGFB1 is linked to polycystic ovary syndrome.